VEN+DAC+Bu2Flu4 vs Bu2Flu5 Conditioning Regimen for Elderly Myeloid Malignancies Undergoing Allo-HSCT

Clinical trial NCT07052422 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07052422
Sponsor: Nanfang Hospital, Southern Medical University
Status: NOT_YET_RECRUITING
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Older Patients Myeloid Malignancies Conditioning Hematopoietic Stem Cell Transplantation (HSCT)

Start date: 2025-07-15
Primary completion: 2027-12-31
Enrollment: 160

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.